TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›TCOM
TCOM logo

TCOM

Trip.com Group Ltd

Next earnings Aug 25, 2026 (after close) · consensus $7.10 EPS, $17.1B rev

Buy
$41.00
▲ +2.60%
$41.00▼ -30.12%
over 1Y
L $39.96H $78.96
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.6%
1W+1.3%
1M-15.4%
3M-18.8%
YTD-45.0%
1Y-30.1%
OverviewFinancialsValuationQualityFilings
Rating
Buy
Quality
B+
Valuation
Undervalued
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 31 analysts
Strong Buy

China's dominant OTA compounding 20%+ revenue growth, debt-light, at just 10.7x earnings — quality on sale.

Revenue $8.93B · FY2025

The read

Quality fundamentals and an attractive price line up (~292% below fair value) — the rarer case where both the business and the entry look good.

Trip.com has executed a textbook post-pandemic recovery, with revenue climbing from $3.14B in FY2021 to $8.93B in FY2025 (+22.2% YoY) and the business swinging from a -$86M loss in FY2021 to $4.76B of net income in FY2025. The economics are those of a high-quality, asset-light online travel platform: 80.6% gross margin, 25.3% operating margin, and a 19.5% return on equity, with capex of just $114M against $2.06B of operating cash flow. The balance sheet is a genuine strength — $24.4B of equity against $13.6B of total liabilities (0.55x liabilities/equity), $5.70B of cash, and long-term debt cut 40.8% to $1.63B — while management is returning capital, doubling buybacks to $629M and paying $204M in dividends.

Valuation is the clincher. At $45.10 the stock trades at 10.7x FY diluted EPS of $4.23 and 3.3x sales for a franchise still growing the top line north of 20%; that is a low-teens multiple on a structurally advantaged grower with net cash and a recovering Chinese and outbound-travel end market. For a long-horizon investor, paying ~11x earnings for a category leader compounding revenue at this rate, with rising shareholder returns, skews the risk/reward favorably.

Is TCOM a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~90d expiry
  • Long call 41 @ ~4.04 est
  • Short call 47 @ ~1.92 est
debit $212max +$388max −$212BE 43.12

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$3.14B$2.91B$6.27B$7.30B$8.93B
Gross profit$2.42B$2.25B$5.13B$5.93B$7.19B
Operating income-$221M$15.0M$1.59B$1.94B$2.26B
Net income-$86.0M$206M$1.40B$2.34B$4.76B
Diluted EPS—————
Net margin-2.7%7.1%22.3%32.0%53.4%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$24.5B
EV / EBITDA—
EV / Sales2.7
EV / FCF12.6
P / FCF13.3
PEG (trailing)0.09
Earnings yield18.4%
FCF yield7.5%

Quality & risk

ROIC (est.)6.2%
Free cash flow$1.95B
Total debt$4.40B
Net cash$1.30B
Altman Z-Score1.78 distress
Piotroski F-Score7/9

Capital returns

Buyback yield2.4%
Dividend yield (est.)0.8%
Shareholder yield3.2%
Shares Δ YoY-0.6%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-302026-06-30open ↗6-KPeriod ending 2026-06-252026-06-25open ↗6-KPeriod ending 2026-06-112026-06-11open ↗6-KPeriod ending 2026-05-272026-05-27open ↗SCHEDULE 13G/AFiling2026-05-14open ↗6-KPeriod ending 2026-04-282026-04-28open ↗SCHEDULE 13G/AFiling2026-04-28open ↗4Period ending 2026-03-182026-04-28open ↗20-FPeriod ending 2025-12-312026-04-28open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗3Period ending 2026-03-182026-03-18open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueA-
GrowthA+
ProfitabilityA+
Financial healthA-
MomentumF
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$160.74

Undervalued +292% vs price

cheapfair valueexpensive

Modified Graham: EPS $4.23 × (8.5 + 1.5 × 22.0% growth) × 1.16 quality = 38.0× multiple. An estimate, not a price target.

39.8452-week78.96
Revenue
$8.93B
+22.2% YoY
Net margin
53.4%
ROE
19.5%
P/E
9.7

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$8.93B+22.2%
Net income$4.76B+103.7%
Gross profit$7.19B+21.2%
Operating income$2.26B+16.2%
Diluted EPS$4.23
Cash & equivalents$5.70B-14.1%
Total assets$38.2B+15.1%
Total liabilities$13.6B-0.2%
Stockholders' equity$24.4B+25.7%
Gross: 80.6%Op.: 25.3%L/E: 0.55x

Frequently asked

Is Trip.com Group Ltd (TCOM) a buy?
TCOM currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. China's dominant OTA compounding 20%+ revenue growth, debt-light, at just 10.7x earnings — quality on sale.
What is TCOM's fair value?
A Modified-Graham model based on TCOM's SEC fundamentals estimates a fair value of about $160.74. It is an estimate from reported earnings, not a price target.
Is TCOM overvalued or undervalued?
Against a Modified-Graham fair-value estimate, TCOM currently appears undervalued relative to its SEC-grounded earnings power.
What is Trip.com Group Ltd's quality score?
TCOM scores 78.11840675030858/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001269238, latest 6-K filed 2026-06-30) · EODHD · Proprietary analysis · as of 6/21/2026, 7:04:16 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 3:04 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Held by tracked funds

Form 13F · SEC · quarterly
Two Sigma Investments2.49M sh$124M
D. E. Shaw & Co.1.54M sh$76.8M
Point72 Asset ManagementSteve Cohen1.09M sh$54.2M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2025-03-17
Last amount
$0.30
ex 2025-03-17paid 2025-04-04$0.30
ex 2008-06-10paid 2008-07-07$0.06
ex 2007-06-27paid 2007-07-05$0.03
ex 2006-06-28paid 2006-07-14$0.03
ex 2005-06-28paid 2005-07-08$0.02

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-11-21Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗
2020-08-19Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2020-08-19Gilbert CisnerosSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score78 vs 67
Revenue growth22.2% vs 7.5%
Net margin53.4% vs 10.0%
Return on equity19.5% vs 12.0%
P/E9.7 vs 26.2